Wu CY, Shapiro L, Ouk M, MacIntosh BJ, Black SE, Shah BR, et al
doi: 10.3389/fendo.2021.735019 Received 01 July 2021 Accepted 18 August 2021 Published 08 September 2021 Volume 12 - 2021 Edited by Peter Flatt, Ulster University, United Kingdom Reviewed by Victor Alan Gault, Ulster University, United Kingdom
It is not for human or animal consumption, not a drug, food, dietary supplement, or cosmetic, and is not intended to diagnose, treat, cure, or prevent any condition
Sanofi-Aventis) that reduces food intake and body weight in humans and is currently in Phase III clinical trials as a weight reduction product (35)
Oral GLP-1 agonists havent quite caught on yet, primarily due to (1) issues with absorption, which necessitates higher dosing than injectables and may impact efficacy, and (2) fasting restrictions (must be taken on an empty stomach)
Since your thyroid is a major hormone powerhouse, anything that disrupts it can create a domino effect throughout your body
